Prelude Capital Management’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-486
| Closed | -$2K | – | 1926 |
|
|
2018
Q4 | $2K | Hold |
486
| – | – | ﹤0.01% | 1326 |
|
|
2018
Q3 | $5K | Sell |
486
-136
| -22% | -$1.4K | ﹤0.01% | 1276 |
|
|
2018
Q2 | $5K | Sell |
622
-218
| -26% | -$1.75K | ﹤0.01% | 1273 |
|
|
2018
Q1 | $5K | Buy |
840
+204
| +32% | +$1.21K | ﹤0.01% | 1267 |
|
|
2017
Q4 | $6K | Sell |
636
-6
| -0.9% | -$57 | ﹤0.01% | 1120 |
|
|
2017
Q3 | $6K | Sell |
642
-402
| -39% | -$3.76K | ﹤0.01% | 1366 |
|
|
2017
Q2 | $13K | Buy |
+1,044
| New | +$13K | ﹤0.01% | 1237 |
|
|
2017
Q1 | – | Sell |
-2,600
| Closed | -$24K | – | 1864 |
|
|
2016
Q4 | $24K | Sell |
2,600
-1,600
| -38% | -$14.8K | ﹤0.01% | 1242 |
|
|
2016
Q3 | $50K | Buy |
+4,200
| New | +$50K | 0.01% | 982 |
|
|
2016
Q1 | – | Sell |
-2,100
| Closed | -$60K | – | 1581 |
|
|
2015
Q4 | $60K | Buy |
2,100
+800
| +62% | +$22.9K | 0.01% | 944 |
|
|
2015
Q3 | $37K | Sell |
1,300
-800
| -38% | -$22.8K | 0.01% | 1053 |
|
|
2015
Q2 | $75K | Buy |
2,100
+500
| +31% | +$17.9K | 0.01% | 926 |
|
|
2015
Q1 | $47K | Sell |
1,600
-5,200
| -76% | -$153K | 0.01% | 1264 |
|
|
2014
Q4 | $143K | Hold |
6,800
| – | – | 0.02% | 804 |
|
|
2014
Q3 | $132K | Sell |
6,800
-3,200
| -32% | -$62.1K | 0.02% | 854 |
|
|
2014
Q2 | $156K | Buy |
+10,000
| New | +$156K | 0.02% | 746 |
|